Press release
Leukapheresis Market is Expected at a CAGR of 8.2% during 2023-2032, Driven by the Increased Prevalence of Hyper Leukocytic Leukemia | Terumo BCT, Macopharma, HemaCare, Caltag Medsystem
The method of leukapheresis is used to remove white blood cells from a blood sample. It is done to lower the number of elevated white blood cells, to gain cells for different types of research, and to collect autologous blood cells for transplanting back into the patient. Leukapheresis is a form of apheresis that removes a component of blood and then reincorporates the remaining blood into circulation. White blood cells are isolated during chemotherapy in order to protect them from potential harm from the high dosage of chemotherapy medications. They are then returned to the patient's body.
Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10318
Market Trends and Drivers
Leukemia incidence has drastically increased across the globe. The American Cancer Society predicts that there will be 61,090 new cases of leukemia in the US in 2021. In addition, it is predicted that leukemia would be responsible for 23,660 fatalities in the US in 2021. Between 2008 and 2020, the incidence rate of leukemia in children increased by 1% year. It is logical to assume that the increased prevalence of hyper leukocytic leukemia will increase the need for therapeutic leukapheresis operations in the next years and support the expansion of the leukapheresis market.
Despite its therapeutic benefits, leukapheresis is still not widely used as a treatment, especially for hyper leukocytic leukemia. But industry participants are starting to pay more attention to how therapeutic leukapheresis is used to treat pediatric patients. The risks and side effects of conventional treatments, such as chemotherapy for children, can be primarily blamed for this. Children's stem cells can be obtained through leukapheresis and utilized to treat or remove extra WBCs in patients with juvenile lymphoma or other cancers. Given that so few hospitals now offer leukapheresis treatment for children in both established and emerging economies, leukapheresis is an area of focus in this market due to the potential and benefits it offers in this application.
Read more about Leukapheresis Market here: https://www.globalinsightservices.com/reports/leukapheresis-market/
Global Leukapheresis Market Segmentation
By Type
• Leukapheresis Devices
• Apheresis Devices
• Leukoreduction Filters
• Leukapheresis Columns & Cell Separators
By Application
• Research Applications
• Therapeutic Applications
By End Users
• Blood Component Providers & Blood Centers
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Transfusion Centers
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o The UK
o Germany
o France
o Spain
o Rest of Europe
• The Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Rest of the World
o Latin America
o The Middle East
o Africa
Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10318
Major Players in the Global Leukapheresis Market
The key players studied in the report are Fresenius, Asahi Kasei Medical, Haemonetics, STEMCELL Technologies, Terumo BCT, Macopharma, HemaCare, Caltag Medsystem, StemExpress, Key Biologics LLC, ZenBio Inc, Digital Pharmacist Inc, BioIVT, Precision for Medicine Inc, and Lmb Technologie GmbH among others.
Purchase This Market Research Report - https://www.globalinsightservices.com/checkout/single_user/GIS10318
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leukapheresis Market is Expected at a CAGR of 8.2% during 2023-2032, Driven by the Increased Prevalence of Hyper Leukocytic Leukemia | Terumo BCT, Macopharma, HemaCare, Caltag Medsystem here
News-ID: 3148236 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Leukapheresis
Leukapheresis Market Future Prediction Report By 2028
Leukapheresis Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Request Sample…
Leukapheresis Market Future Prediction Report By 2028
Leukapheresis Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Download…
Leukapheresis Market Outlook and Major Regions' Development Status
Global Leukapheresis Market Report is a professional and in-depth survey on the current state of the Leukapheresis Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Leukapheresis Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00005515?utm_source=OpenPR&utm_medium=10867
Key Players Analysis:
Asahi Kasei Corporation
Fresenius SE & Co. KGaA
Haemonetics Corporation
Terumo Corporation
STEMCELL…
Leukapheresis Market Global Rising Demand & Huge Scope Till 2028
Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers) The leukapheresis market is expected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow…
Leukapheresis Market worth $100 million by 2028
Leukapheresis Market in terms of revenue was estimated to be worth $70 million in 2023 and is poised to reach $100 million by 2028, growing at a CAGR of 8.3 % from 2023 to 2028 according to a new report by MarketsandMarkets™. The global leukopaks market is anticipated to reach USD 1020 million by 2028 from USD 200 million in 2023, at a CAGR of 38.1%. The leukopaks market…
Leukapheresis Market - Advancing Cellular Medicine: Leukapheresis Driving Breakt …
Newark, New Castle, USA: The "Leukapheresis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Leukapheresis Market: https://www.growthplusreports.com/report/leukapheresis-market/8784
This latest report researches the industry structure, sales, revenue, price and…
